Adalimumab
Also known as Humira (us), Exemptia (india)
A TNF-inhibitor biologic (and biosimilars) for rheumatoid arthritis, psoriasis, Crohn’s and more.
Based on 2 pens per month. US $2,984.00 vs India $120.00 per pen.
The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.
- Medicine savings over 6 months
- $34,368
- Estimated travel cost
- − $2,300
- Net savings after travel
- $32,068
Even after travel, you could come out ahead by about $32,068.
Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.
Adalimumab is filled about 652K times a year under Medicare Part D. At the prices above, that works out to roughly:
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.